Informations générales (source: ClinicalTrials.gov)
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: A Prospective Cross Over Trial
Interventional
N/A
University Hospital, Angers (Voir sur ClinicalTrials)
septembre 2004
29 juin 2024
This study aims to evaluate the impact of nasal continuous positive airway pressure
(nCPAP) treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic
steatohepatitis. Using a cross over design, the evolution of liver enzymes will be
evaluated in 40 patients during a consecutive period of 6 weeks, with and without nCPAP
treatment.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| University Hospital Angers - Angers - France | Frédéric Gagnadoux, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- 18 to 70 years old
- Nonalcoholic steatohepatitis proven by liver biopsy
- Sleep apnea syndrome proven by polysomnography with an apnea-hypopnea index > 10
events/hour
- Informed consent
- 18 to 70 years old
- Nonalcoholic steatohepatitis proven by liver biopsy
- Sleep apnea syndrome proven by polysomnography with an apnea-hypopnea index > 10
events/hour
- Informed consent
- Psychiatric disorder
- Other cause of liver disease
- Professional driver